Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)
Clinical trial NCT06517511 · RECRUITING
Trial details
- NCT number
- NCT06517511
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2027-01-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.